Table 1.
Demographic and clinical baseline characteristics of study participants presented in cases and controls and by prior atrial fibrillation status among cases and controls (n = 19,991).
Table 2.
Crude and adjusted odds ratios (ORs)* for the association of exposure to atrial fibrillation and cancer in the case-control analysis (n = 19,991).
Table 3.
Crude and adjusted hazard ratios (HRs)* for the association of exposure to cancer and new incident atrial fibrillation in the cohort analysis (n = 19,101).